These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21208543)

  • 1. [A randomized clinical trial of gemcitabine plus cisplatin compared with gemcitabine plus vinorelbine in the treatment of non-small cell lung cancer].
    Zhang L; Li N; Xu F; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2005 Dec; 8(6):530-4. PubMed ID: 21208543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].
    Zhang L; Zhang Y; Li N; Xu F; Pan ZK; Guan ZZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1455-8. PubMed ID: 15566656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Randomized clinical study comparing gemcitabine and oxaliplatin versus gemcitabine and cisplatin for advanced non-small cell lung cancer in elderly patients].
    Sun Q; Hua J; Hang X; Mao Y; Wang Q
    Zhongguo Fei Ai Za Zhi; 2005 Oct; 8(5):451-3. PubMed ID: 21205532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study on gemcitabine plus cisplatin and vinorelbine plus ifosfamide plus cisplatin combined chemotherapy in the treatment of advanced non-small cell lung cancer].
    Zhao Y; Chen Y; Ji H; Chu T; Han B; Liao M
    Zhongguo Fei Ai Za Zhi; 2004 Oct; 7(5):449-51. PubMed ID: 21244803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Randomized clinical trial of paclitaxel plus cisplatin versus gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer].
    Gou H; Chen X; Hou M; Yang Y
    Zhongguo Fei Ai Za Zhi; 2007 Apr; 10(2):141-3. PubMed ID: 21114939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gemcitabine plus cisplatin versus navelbine plus cisplatin in the treatment of advanced non-small cell lung cancer].
    Fan Y; Luo L
    Zhongguo Fei Ai Za Zhi; 2003 Dec; 6(6):499-501. PubMed ID: 21310141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic efficacy of chemotherapy combined with radiotherapy in 527 patients with stage III and IV non-small cell lung cancer].
    Wang A; Zhou H; Wen X; Yi Q; Zhou W; Wang W; Yao D; Xu J; Huang Z
    Zhongguo Fei Ai Za Zhi; 2007 Jun; 10(3):219-22. PubMed ID: 21118650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer].
    Wang H; Jiang N
    Zhongguo Fei Ai Za Zhi; 2005 Jun; 8(3):223-6. PubMed ID: 21190625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A randomized study of docetaxel plus cisplatin versus paclitaxel plus cisplatin in previously untreated advanced non-small cell lung cancer.].
    Zhang S; Wang J; Wang Q; Yang X; Hu F; Li X; Gu Y; Wang H
    Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):110-4. PubMed ID: 20727278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A Meta-Analysis of Platinum Plus Gemcitabine or Vinorelbine for Advanced Non-small Cell Lung Cancer.].
    Gao G; Zhou X; Huang R; Jiang J; Chu Z; Zhan Q; Liang X
    Zhongguo Fei Ai Za Zhi; 2009 Jan; 12(1):38-43. PubMed ID: 20712955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination of GP regimen and Kanglaite in the treatment of advanced non-small cell lung cancer].
    Lian Z; Lu Y; Hou E; Wang X
    Zhongguo Fei Ai Za Zhi; 2006 Feb; 9(1):74-7. PubMed ID: 21144288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized clinical trial on taxol plus oxaliplatin versus taxol plus cisplatin as first-line treatment in advanced non-small cell lung cancer].
    Li M; Huang H; Tan J; Lin D
    Zhongguo Fei Ai Za Zhi; 2006 Oct; 9(5):452-4. PubMed ID: 21176470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer.
    Yasuda H; Yamaya M; Nakayama K; Sasaki T; Ebihara S; Kanda A; Asada M; Inoue D; Suzuki T; Okazaki T; Takahashi H; Yoshida M; Kaneta T; Ishizawa K; Yamanda S; Tomita N; Yamasaki M; Kikuchi A; Kubo H; Sasaki H
    J Clin Oncol; 2006 Feb; 24(4):688-94. PubMed ID: 16446342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Randomly clinical study of vinorelbine/cisplatin and vinorelbine/oxaliplatin regimens in the treatment of advanced non-small cell lung cancer].
    Wang X; Hou M; Cao D; Gou H; Yang Y
    Zhongguo Fei Ai Za Zhi; 2006 Feb; 9(1):71-3. PubMed ID: 21144287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The comparison of efficacy between GP and NP regimens in the treatment of advanced non-small cell lung cancer].
    Tian L; Wang Z; Liu D
    Zhongguo Fei Ai Za Zhi; 2002 Dec; 5(6):432-4. PubMed ID: 21333224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].
    Wang J; Sun Y; Liu Y; Yu Q; Zhang Y; Li K; Zhu Y; Zhou Q; Hou M; Guan Z; Li W; Zhuang W; Wang D; Liang H; Qin F; Lu H; Liu X; Sun H; Zhang Y; Wang J; Luo S; Yang R; Tu Y; Wang X; Song S; Zhou J; You L; Wang J; Yao C
    Zhongguo Fei Ai Za Zhi; 2005 Aug; 8(4):283-90. PubMed ID: 21108883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation on survival in locally advanced non-small cell lung cancer (NSCLC) for multimodality treatment with or without operation].
    Li J; Ma S; Kang S; Xie J; Sheng X; Luo R
    Zhongguo Fei Ai Za Zhi; 2005 Dec; 8(6):535-7. PubMed ID: 21208544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.